Loading…

Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations

Objective:  To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations. Method:  Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of...

Full description

Saved in:
Bibliographic Details
Published in:Acta psychiatrica Scandinavica 2003-05, Vol.107 (5), p.361-368
Main Authors: Stant, A. D., TenVergert, E. M., Groen, H., Jenner, J. A., Nienhuis, F. J., van de Willige, G., Wiersma, D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43
cites cdi_FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43
container_end_page 368
container_issue 5
container_start_page 361
container_title Acta psychiatrica Scandinavica
container_volume 107
creator Stant, A. D.
TenVergert, E. M.
Groen, H.
Jenner, J. A.
Nienhuis, F. J.
van de Willige, G.
Wiersma, D.
description Objective:  To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations. Method:  Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of 18 months for patients who received the HIT programme and for patients in the care as usual (CAU) condition. The Positive and Negative Syndrome Scale (PANSS) was used as main outcome measure in the cost‐effectiveness analysis. Bootstrap analyses provided additional information on the skewly distributed costs. Results:  Mean costs per patient in the HIT group ($18 237) were lower than the mean costs per patient in the CAU group ($21 436). Results of the PANSS were slightly in favour of the HIT group. Conclusion:  There appears to be no significant cost‐effectiveness advantage of the HIT programme over CAU. Additional analyses indicated that future application of the HIT programme will, in most cases, lead to a reduction of (non) medical costs.
doi_str_mv 10.1034/j.1600-0447.2003.00102.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73268612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73268612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43</originalsourceid><addsrcrecordid>eNqNkEuP0zAURi0EYsrAX0DewC7h-hEnWbAYVdCONAIkBoHYWK5zQ1zywk6Yll-PQ6uZLSu_znf96RBCGaQMhHyzT5kCSEDKPOUAIgVgwNPDI7K6f3hMVhCvE1XCtwvyLIR9PGYMiqfkgvE84yD4inTrIUwJ1jXayf3GHkOgQ02nBun2-paOfvjhTdchdT0dzeSwnwK9c1NDg23cn2FsPPbOUNNXdEQfXJgiQs1cuWnwR9qYtp2t62N06MNz8qQ2bcAX5_WSfHn_7na9TW4-bq7XVzeJlULwpEIlS5YpvuM2A4EyFwyBGVtVhRSlLTJUtZKsgtqonamxqDhKniuZ57Kspbgkr09zY_9fM4ZJdy5YbFvT4zAHnQuuCsV4BIsTaP0Qgsdaj951xh81A72o1nu9GNWLUb2o1v9U60OMvjz_Me86rB6CZ7cReHUGTLCmrb3prQsPnCxAlHwp-_bE3bkWj_9dQF-tP32Ou5hPTvnF_eE-b_xPrXKRZ_rrh42WavMdtptSF-IvCD6qOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73268612</pqid></control><display><type>article</type><title>Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Stant, A. D. ; TenVergert, E. M. ; Groen, H. ; Jenner, J. A. ; Nienhuis, F. J. ; van de Willige, G. ; Wiersma, D.</creator><creatorcontrib>Stant, A. D. ; TenVergert, E. M. ; Groen, H. ; Jenner, J. A. ; Nienhuis, F. J. ; van de Willige, G. ; Wiersma, D.</creatorcontrib><description>Objective:  To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations. Method:  Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of 18 months for patients who received the HIT programme and for patients in the care as usual (CAU) condition. The Positive and Negative Syndrome Scale (PANSS) was used as main outcome measure in the cost‐effectiveness analysis. Bootstrap analyses provided additional information on the skewly distributed costs. Results:  Mean costs per patient in the HIT group ($18 237) were lower than the mean costs per patient in the CAU group ($21 436). Results of the PANSS were slightly in favour of the HIT group. Conclusion:  There appears to be no significant cost‐effectiveness advantage of the HIT programme over CAU. Additional analyses indicated that future application of the HIT programme will, in most cases, lead to a reduction of (non) medical costs.</description><identifier>ISSN: 0001-690X</identifier><identifier>EISSN: 1600-0447</identifier><identifier>DOI: 10.1034/j.1600-0447.2003.00102.x</identifier><identifier>PMID: 12752032</identifier><identifier>CODEN: APYSA9</identifier><language>eng</language><publisher>Oxford, UK: Munksgaard International Publishers</publisher><subject>Adult ; Associated treatments ; Biological and medical sciences ; Cost of Illness ; Cost Savings ; Cost-Benefit Analysis ; cost-benefit analysis (cost-effectiveness) ; costs and cost analysis ; Female ; hallucinations ; Hallucinations - economics ; Hallucinations - etiology ; Hallucinations - therapy ; Humans ; Male ; Medical sciences ; Middle Aged ; Netherlands ; Outcome Assessment (Health Care) - statistics &amp; numerical data ; Patient Compliance ; Patient Satisfaction ; Program Evaluation ; Prospective Studies ; Psychiatric Status Rating Scales ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; schizophrenia ; Schizophrenia - complications ; Schizophrenia - economics ; Schizophrenia - therapy ; therapy ; Treatments</subject><ispartof>Acta psychiatrica Scandinavica, 2003-05, Vol.107 (5), p.361-368</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43</citedby><cites>FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14803924$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12752032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stant, A. D.</creatorcontrib><creatorcontrib>TenVergert, E. M.</creatorcontrib><creatorcontrib>Groen, H.</creatorcontrib><creatorcontrib>Jenner, J. A.</creatorcontrib><creatorcontrib>Nienhuis, F. J.</creatorcontrib><creatorcontrib>van de Willige, G.</creatorcontrib><creatorcontrib>Wiersma, D.</creatorcontrib><title>Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations</title><title>Acta psychiatrica Scandinavica</title><addtitle>Acta Psychiatr Scand</addtitle><description>Objective:  To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations. Method:  Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of 18 months for patients who received the HIT programme and for patients in the care as usual (CAU) condition. The Positive and Negative Syndrome Scale (PANSS) was used as main outcome measure in the cost‐effectiveness analysis. Bootstrap analyses provided additional information on the skewly distributed costs. Results:  Mean costs per patient in the HIT group ($18 237) were lower than the mean costs per patient in the CAU group ($21 436). Results of the PANSS were slightly in favour of the HIT group. Conclusion:  There appears to be no significant cost‐effectiveness advantage of the HIT programme over CAU. Additional analyses indicated that future application of the HIT programme will, in most cases, lead to a reduction of (non) medical costs.</description><subject>Adult</subject><subject>Associated treatments</subject><subject>Biological and medical sciences</subject><subject>Cost of Illness</subject><subject>Cost Savings</subject><subject>Cost-Benefit Analysis</subject><subject>cost-benefit analysis (cost-effectiveness)</subject><subject>costs and cost analysis</subject><subject>Female</subject><subject>hallucinations</subject><subject>Hallucinations - economics</subject><subject>Hallucinations - etiology</subject><subject>Hallucinations - therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Netherlands</subject><subject>Outcome Assessment (Health Care) - statistics &amp; numerical data</subject><subject>Patient Compliance</subject><subject>Patient Satisfaction</subject><subject>Program Evaluation</subject><subject>Prospective Studies</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>schizophrenia</subject><subject>Schizophrenia - complications</subject><subject>Schizophrenia - economics</subject><subject>Schizophrenia - therapy</subject><subject>therapy</subject><subject>Treatments</subject><issn>0001-690X</issn><issn>1600-0447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNkEuP0zAURi0EYsrAX0DewC7h-hEnWbAYVdCONAIkBoHYWK5zQ1zywk6Yll-PQ6uZLSu_znf96RBCGaQMhHyzT5kCSEDKPOUAIgVgwNPDI7K6f3hMVhCvE1XCtwvyLIR9PGYMiqfkgvE84yD4inTrIUwJ1jXayf3GHkOgQ02nBun2-paOfvjhTdchdT0dzeSwnwK9c1NDg23cn2FsPPbOUNNXdEQfXJgiQs1cuWnwR9qYtp2t62N06MNz8qQ2bcAX5_WSfHn_7na9TW4-bq7XVzeJlULwpEIlS5YpvuM2A4EyFwyBGVtVhRSlLTJUtZKsgtqonamxqDhKniuZ57Kspbgkr09zY_9fM4ZJdy5YbFvT4zAHnQuuCsV4BIsTaP0Qgsdaj951xh81A72o1nu9GNWLUb2o1v9U60OMvjz_Me86rB6CZ7cReHUGTLCmrb3prQsPnCxAlHwp-_bE3bkWj_9dQF-tP32Ou5hPTvnF_eE-b_xPrXKRZ_rrh42WavMdtptSF-IvCD6qOA</recordid><startdate>200305</startdate><enddate>200305</enddate><creator>Stant, A. D.</creator><creator>TenVergert, E. M.</creator><creator>Groen, H.</creator><creator>Jenner, J. A.</creator><creator>Nienhuis, F. J.</creator><creator>van de Willige, G.</creator><creator>Wiersma, D.</creator><general>Munksgaard International Publishers</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200305</creationdate><title>Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations</title><author>Stant, A. D. ; TenVergert, E. M. ; Groen, H. ; Jenner, J. A. ; Nienhuis, F. J. ; van de Willige, G. ; Wiersma, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Associated treatments</topic><topic>Biological and medical sciences</topic><topic>Cost of Illness</topic><topic>Cost Savings</topic><topic>Cost-Benefit Analysis</topic><topic>cost-benefit analysis (cost-effectiveness)</topic><topic>costs and cost analysis</topic><topic>Female</topic><topic>hallucinations</topic><topic>Hallucinations - economics</topic><topic>Hallucinations - etiology</topic><topic>Hallucinations - therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Netherlands</topic><topic>Outcome Assessment (Health Care) - statistics &amp; numerical data</topic><topic>Patient Compliance</topic><topic>Patient Satisfaction</topic><topic>Program Evaluation</topic><topic>Prospective Studies</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>schizophrenia</topic><topic>Schizophrenia - complications</topic><topic>Schizophrenia - economics</topic><topic>Schizophrenia - therapy</topic><topic>therapy</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stant, A. D.</creatorcontrib><creatorcontrib>TenVergert, E. M.</creatorcontrib><creatorcontrib>Groen, H.</creatorcontrib><creatorcontrib>Jenner, J. A.</creatorcontrib><creatorcontrib>Nienhuis, F. J.</creatorcontrib><creatorcontrib>van de Willige, G.</creatorcontrib><creatorcontrib>Wiersma, D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta psychiatrica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stant, A. D.</au><au>TenVergert, E. M.</au><au>Groen, H.</au><au>Jenner, J. A.</au><au>Nienhuis, F. J.</au><au>van de Willige, G.</au><au>Wiersma, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations</atitle><jtitle>Acta psychiatrica Scandinavica</jtitle><addtitle>Acta Psychiatr Scand</addtitle><date>2003-05</date><risdate>2003</risdate><volume>107</volume><issue>5</issue><spage>361</spage><epage>368</epage><pages>361-368</pages><issn>0001-690X</issn><eissn>1600-0447</eissn><coden>APYSA9</coden><abstract>Objective:  To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations. Method:  Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of 18 months for patients who received the HIT programme and for patients in the care as usual (CAU) condition. The Positive and Negative Syndrome Scale (PANSS) was used as main outcome measure in the cost‐effectiveness analysis. Bootstrap analyses provided additional information on the skewly distributed costs. Results:  Mean costs per patient in the HIT group ($18 237) were lower than the mean costs per patient in the CAU group ($21 436). Results of the PANSS were slightly in favour of the HIT group. Conclusion:  There appears to be no significant cost‐effectiveness advantage of the HIT programme over CAU. Additional analyses indicated that future application of the HIT programme will, in most cases, lead to a reduction of (non) medical costs.</abstract><cop>Oxford, UK</cop><pub>Munksgaard International Publishers</pub><pmid>12752032</pmid><doi>10.1034/j.1600-0447.2003.00102.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-690X
ispartof Acta psychiatrica Scandinavica, 2003-05, Vol.107 (5), p.361-368
issn 0001-690X
1600-0447
language eng
recordid cdi_proquest_miscellaneous_73268612
source Wiley-Blackwell Read & Publish Collection
subjects Adult
Associated treatments
Biological and medical sciences
Cost of Illness
Cost Savings
Cost-Benefit Analysis
cost-benefit analysis (cost-effectiveness)
costs and cost analysis
Female
hallucinations
Hallucinations - economics
Hallucinations - etiology
Hallucinations - therapy
Humans
Male
Medical sciences
Middle Aged
Netherlands
Outcome Assessment (Health Care) - statistics & numerical data
Patient Compliance
Patient Satisfaction
Program Evaluation
Prospective Studies
Psychiatric Status Rating Scales
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
schizophrenia
Schizophrenia - complications
Schizophrenia - economics
Schizophrenia - therapy
therapy
Treatments
title Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A14%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost-effectiveness%20of%20the%20HIT%20programme%20in%20patients%20with%20schizophrenia%20and%20persistent%20auditory%20hallucinations&rft.jtitle=Acta%20psychiatrica%20Scandinavica&rft.au=Stant,%20A.%20D.&rft.date=2003-05&rft.volume=107&rft.issue=5&rft.spage=361&rft.epage=368&rft.pages=361-368&rft.issn=0001-690X&rft.eissn=1600-0447&rft.coden=APYSA9&rft_id=info:doi/10.1034/j.1600-0447.2003.00102.x&rft_dat=%3Cproquest_cross%3E73268612%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73268612&rft_id=info:pmid/12752032&rfr_iscdi=true